Novartis AG (NVS)
160.06
+1.86
(+1.18%)
USD |
NYSE |
Feb 11, 16:00
159.66
-0.40
(-0.25%)
Pre-Market: 07:36
Novartis Profit Margin (Quarterly) : 18.03% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Roche Holding AG | -- |
| Amgen, Inc. | 13.51% |
| AstraZeneca PLC | 15.02% |
| Gilead Sciences, Inc. | 27.55% |
| Regeneron Pharmaceuticals, Inc. | 21.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 32.47% |
| Return on Assets | 13.13% |
| Return on Invested Capital | 18.52% |
| Gross Profit Margin (Quarterly) | 73.44% |
| Operating Margin (Quarterly) | 26.40% |
| Return on Net Operating Assets | 17.43% |